4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001501697-26-000049
Chief Financial Officer sold 16,961 shares at $4.29 ($72,820)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KIRSKE DAVID Chief Financial Officer | 2026-05-12 | Sale | −16,961 | $4.29 | $72,820 | 176,293 | D |
| Open-market sales · 16,961 sh · avg $4.29 · $72,820 | |||||||
Loading xslF345X06/wk-form4_1778702561.xml…